High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure

Nephron

Volumn 82, Issue 2, 1999, Pages 164-173

  Gotloib, Lazaro ^a   Shostak, Avshalom ^a   Wajsbrot, Valery ^a   Kushnier, Raisa ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Biocompatibility; Dialysis fluid; Mesothelial cell cycle; Mesothelial cell imprints; Osmotic agents; Peritoneal dialysis

Indexed keywords

BUFFER; GLUCOSE; PERITONEAL DIALYSIS FLUID;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL AGING; CELL CYCLE; CELL DEATH; CELL DENSITY; CELL VIABILITY; CONTROLLED STUDY; HYPERTROPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MEMBRANE FILTER; MESOTHELIUM CELL; MITOSIS; MOUSE; MULTINUCLEAR CELL; NONHUMAN; PH; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL NUCLEUS; CELL SURVIVAL; CULTURE MEDIA; CYTOPLASM; EPITHELIAL CELLS; GLUCOSE; HYDROGEN-ION CONCENTRATION; MICE; MITOSIS; PERITONEUM; PHENOTYPE;

EID: 0032989838     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045393     Document Type: Article

References (56)

1. Jorres A, Topley N, Gahl GM: Biocompatibility of peritoneal dialysis fluids (editorial). Int J Artif Organs 1992;15:79-83.
2. Liberek T, Topley N, Jones A, Coles GA, Gahl GM, Williams JD: Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration. J Am Soc Nephrol 1993;3:1508-1515.
3. Breborowicz A: In vitro study on the biocompatibility of the peritoneal dialysis solution. Perit Dial Int 1992;13(suppl 2):105-108.
4. Shostak A, Pivinik K, Gotloib L: Daily short exposure of cultured mesothelial cells to lactated, high glucose, low pH peritoneal dialysis fluid induces a low profile regenerative steady state. Nephrol Dial Transplant 1996;11:608-613.
5. Martinson E, Wieslander A, Kjellstrand P, Boberg V: Toxicity of heat sterilized peritoneal dialysis fluids is derived from the degradation of glucose. ASAIO J 1992;38:M370-M372.
6. Gotloib L, Wajsbrot V, Shostak A, Kushnier R: Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions. Nephron 1995;70:466-477.
7. Gotloib L, Shostak A: Large mesothelial cells in peritoneal dialysis: A sign of degeneration or adaptation? Pent Dial Int 1996;16:118-120.
8. Gotloib L, Shostak A, Wajsbrot V, Kushnier R: The cytochemical profile of visceral mesothelium under the influence of lactated-hyperosmolar peritoneal dialysis solutions. Nephron 1995;69:466-471.
9. Gotloib L, Shostak A, Wajsbrot V: Detrimental effects of peritoneal dialysis solutions upon in vivo and in situ exposed mesothelium. Pent Dial Int 1997;17(suppl 2):13-16.
10. Gotloib L, Wajsbrot V, Shostak A, Kushnier R: Effect of hyperosmolarity upon the mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution. Nephron 1999;81:301-309.
11. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, Bernini M, Pucci AM, Ibba L, Sabatelli P: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986;44:204-211.
12. Institute of Laboratory Animal Resources: Guide for the Care and Use of Laboratory Animals. DHEW Pub. No. (NIH) 72-73. Washington, National Institute of Health, 1972.
13. Mitruka BM, Rawnsley HM, Vedehra DV: Animals for Medical Research. Models for the Study of Human Disease. New York, Wiley, 1976, p 24.
14. Taylor RB, Jappy BM, Neil JM: Kinetics of dextrose degradation under autoclaving conditions. J Pharm Pharmacol 1972;24:121-129.
15. Scott WM, Ray PM: Euthanasia; in The UFAW Handbook on the Care and Management of Laboratory Animals ed 4. Edinburgh, Churchill-Livingstone, 1972, pp 158-166.
16. Rohlf FJ, Sokal RR: Statistical Tables. San Francisco, Freeman, 1981, pp 71-75.
17. Weibel ER, Staubl W, Gnagi HR, Hess FA: Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereological methods, and normal morphometric data for rat liver. J Cell Biol 1969;42: 68-91.
18. Glantz SA: Primer of Biostatistics. New York, McGraw-Hill, 1992, pp 155-187.
19. Glantz SA: Primer of Biostatistics. New York, McGraw-Hill, 1992, pp 91-109.
20. Pendergrass W, Angello J, Norwood TH: The relationship between cell size, the activity of DNA polymerase alpha and the proliferative activity in human diploid fibroblast-like cell cultures. Exp Gerontol 1989;24:383-393.
21. Angello JC, Pendergrass WR, Norwood TH, Prothero J: Cell enlargement: One possible mechanism underlying cellular senescence. J Cell Physiol 1989;140:288-294.
22. Morris RG, Hargreaves AD, Duvall E, Wyllie AH: Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol 1984;115:426-436.
23. Bonelli G, Sacchi MC, Barbiero G, Duranti F, Goglio G, Verdun-di-Cantogno L, Amenta JS, Piacentini M, Tacchetti G, Baccino FN: Apoptosis of L929 cells by etoposide: A quantitative and kinetic approach. Exp Cell Res 1996;228: 292-305.
24. Wolf G, Sharma K, Chen Y, Erickson M, Ziyadeh F: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 1992;42:647-656.
25. Stout RW: Glucose inhibits replication of cultured human endothelial cells. Diabetologia 1982;23:436-439.
26. Sibbitt WL Jr, Mills RG, Bigler CF, Eaton RP, Griffey RH, Vander-Jagt DL: Glucose inhibition of human fibroblast proliferation and response to growth factors is prevented by inhibitors of aldose reductase. Mech Ageing Dev 1989;47:265-279.
27. Guh JY, Yang ML, Yang YL, Chang CC, Chuang LY: Captopril reverses high-glucose induced growth effects on LLC-Pk cells partly by decreasing transforming growth factor-β receptor expressions. J Am Soc Nephrol 1996;7: 1207-1215.
28. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990;259:F704-F714.
29. Lorenzi M, Nordberg JA, Toledo S: High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 1987;36: 1261-1267.
30. Yang YL, Guh JY, Yang ML, Lai YJ, Tsai JH, Hung WC, Chang CC, Chuang LY: Interaction between high glucose and TGF-β in cell cycle protein regulations in MDCK cells. J Am Soc Nephrol 1998;9:182-193.
31. Morocutti A, Earle KA, Sethi M, Piras G, Pal K, Richards D, Rodemann P, Viberti G: Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease. Kidney Int 1996;50:250-256.
32. Lorenzi M, Cagliero E, Toledo S: Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 1985;34:621-627.
33. Hirano A, Kurimura T: Inhibition of multinucleation of cells treated with cytochalasin-B by cyclic dibutyryl. Gann 1975;66:565-568.
34. Hickey I, McConville G, McMenamin M, Neill R: Effect of cytochalasin B on somatic cell hybrids between normal and transformed cells. J Cell Sci 1985;78:87-96.
35. Traganos F, Gong J, Ardelt B, Darzynkiewicz Z: Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis. J Cell Physiol 1994;158:535-544.
36. Satterwhite LL, Pollard TD: Cytokinesis. Curr Opin Cell Biol 1992;4:43-52.
37. 2: Senescence-like growth arrest or apoptosis? Cell Growth Differ 1997;8:588-598.
38. Vincent F, Brun H, Clain E, Ronot X, Adolphe M: Effects of oxygen-free radicals on proliferation kinetics of cultured rabbit articular chondrocytes. J Cell Physiol 1989;141:262-266.
39. De-Bono DP, Yang WD: Exposure to low concentrations of hydrogen peroxide causes delayed endothelial cell death and inhibits proliferation of surviving cells. Artherosclerosis 1995:114:235-245.
40. Nicotera P, Dypbukt JN, Rossi AD, Manzo L, Orrenius S: Thiol modification and cell signalling in chemical toxicity. Toxicol Lett 1992;64-65:563-567.
41. Dypbukt JM, Ankarcrona M, Burkitt M, Sjoholm A, Strom K, Orrenius S, Nicotera P: Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. J Biol Chem 1994;269:30553-30560.
42. Wiese AG, Pacifici RE, Davies KH: Transient adaptation of oxidative stress in mammalian cells. Arch Biochem Biophys 1995;318:231-240.
43. Curcio F, Ceriello A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 1992;28A:787-790.
44. Shostak A, Pivnik E, Gotloib L: Cultured rat mesothelial cells generate hydrogen peroxide: A new player in peritoneal defense? J Am Soc Nephrol 1996;7:2371-2378.
45. 2: in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 1994;37:264-269.
46. Breborowicz A, Witowski J, Wieczorowska K, Martis L, Serkes KD, Oreopoulos DG: Toxicity of free radicals to mesothelial cells and peritoneal membrane. Nephron 1993;63:62-66.
47. Grankvist K, Sehlin J, Taljedal IB: Rubidium uptake by mouse pancreatic islets exposed to 6-hydroxydopamine, ninhydrin, or other generators of hydroxyl radicals. Acta Pharmacol Toxicol Copenh. 1986;58:175-181.
48. Grankvist K: Gossypol-induced free radical toxicity to isolated islet cells. Int J Biochem 1989;21:853-856.
49. Okada F, Hosokawa M, Hasegawa J, Kuramitsu Y, Nakai K, Yuan L, Lao H, Kobayashi H, Takeichi N: Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells. Br J Cancer 1994;70:233-238.
50. Donnini D, Zambito AM, Perrella G, Amabesi-Impiombato FS, Curcio F: Glucose may induce cell death through a free radical mediated mechanism. Biochem Biophys Res Commun 1996;219:412-417.
51. Kashwem A, Nomoto Y, Tanabe R, Nishina M, Endoh H, Nakajima K, Endoh M, Sakai H, Nakasawa H: The effect of dialysate glucose on phagocyte Superoxide generation in CAPD patients. Perit Dial Int 1998;18:52-59.
52. Elgawich A, Glomb M, Friedlander M, Monnier VM: Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 1996;271:12964-12971.
53. Friedlander MA, Wu Ych, Elgawich A, Monnier VM: Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 1996;3: 728-735.
54. Kjellstrand P, Martinson E, Wieslander A, Holmquist B: Development of toxic degradation products during heat sterilization of glucose containing fluids for peritoneal dialysis: Influence of time and temperature. Peril Dial Int 1995;15:26-32.
55. Gotloib L, Wajsbrot V, Shostak A, Kushnier R: Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid. Nephron 1996;73:219-227.
56. 2 and cGMP. Am J Physiol 1993;264: L141-L145.